Beamion LUNG‑1 Trial: Zongertinib in HER2-Positive NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Beamion LUNG‑1 Trial: Zongertinib in HER2-Positive NSCLC | Targete…
1 week ago
targetedonc.com
Zongertinib in Treatment-Naïve Patients With HER2-mutant NSCLC, Including Those With Active Brain Metastases: Beamion LUNG-1 | OncLive
Zongertinib in Treatment-Naïve Patients With HER2-mutant NSCL…
1 month ago
onclive.com
Boehringer's zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
Boehringer's zongertinib shows encouraging efficacy and tolerabil…
Sep 9, 2024
financialpost.com
Beamion LUNG-1: Zongertinib in Advanced HER2-Mutated NSCLC | OncLive
5:59
Beamion LUNG-1: Zongertinib in Advanced HER2-Mutated NSCLC | …
May 15, 2024
onclive.com
Dr Baik on the Clinical Utility of Zongertinib in Previously Treated HER2-Mutant NSCLC | OncLive
Dr Baik on the Clinical Utility of Zongertinib in Previously Treated …
Nov 6, 2024
onclive.com
Beamion LUNG-1: Examining the Efficacy and Safety of Zongertinib in 2L Treatment of mNSCLC With HER2 Mutations | OncLive
Beamion LUNG-1: Examining the Efficacy and Safety of Zongertinib …
7 months ago
onclive.com
Dr Heymach on the Efficacy of Zongertinib in Previously Treated HER2-Mutant NSCLC | OncLive
2:17
Dr Heymach on the Efficacy of Zongertinib in Previously Treated …
Apr 29, 2025
onclive.com
FDA Approval of Hernexeos (zongertinib) for Patients with HER…
718 views4 months ago
linkedin.com
Efficacy and Safety of Zongertinib in Previously Treated and Treatment …
3 months ago
ajmc.com
Dr Halmos on the FDA Approval of Zongertinib in HER2 TKD–Mutate…
2 months ago
onclive.com
Evaluating Zongertinib After ADC Therapy: Efficacy, Safety, and ILD …
4 months ago
onclive.com
FDA verleiht Boehringer Ingelheims HERNEXEOS den Status einer bah…
8 months ago
marketscreener.com
Boehringer's zongertinib receives Priority Review from U.S. FDA for …
Feb 19, 2025
financialpost.com
2:45
Dr Sabari on the Activity of Zongertinib in Pretreated, Advanc…
May 15, 2025
onclive.com
FDA Grants Accelerated Approval to Zongertinib for Unresectable or M…
2 months ago
onclive.com
0:44
The Royal Marsden NHS Foundation Trust on Instagram: "A trial testin…
19.9K views6 months ago
Instagramroyalmarsdennhs
Beamion Lung 1: Zongertinib (BI 1810631) in Advanced HER2 NSCL…
Jan 12, 2024
onclive.com
# Hernexeos : Première thérapie orale pour CNPPC HER2 approuvé…
Feb 28, 2024
nouvelles-du-monde.com
0:57
PROs in the Beamion LUNG-1 of zongertinib in HER2-mutated NSCLC
182 views11 months ago
YouTubeVJOncology
First-Line Targeted Therapy Shows Antitumor Activity in Patients wit…
1 month ago
newswise.com
1:37
Zongertinib 71% ORR for HER2-Mutant NSCLC: Key Insights from …
May 2, 2025
oncologytube.com
7:01
HERNEXEOS: A Targeted Approach to HER2-Mutated Non-Small Cell L…
92 views9 months ago
YouTubeDiseases and Medicines
0:31
Hernexeos (zongertinib) receives accelerated FDA approval for prev…
14 views9 months ago
FacebookXtalks Webinars
Boehringer Ingelheim provides details of its FDA approved lung c…
9 months ago
marketscreener.com
Emerging Oral HER2-Targeted TKIs (Zongertinib and Sevabertinib): Eff…
11 months ago
onclive.com
Boehringer Ingelheim Limited: U.S. FDA grants accelerated approval t…
9 months ago
finanznachrichten.de
2:58
Zongertinib New Hope for Lung Cancer
66 views1 week ago
YouTubeScienOMed
Hernexeos and what’s next, with Vicky Brown
1 month ago
pharmaphorum.com
Boehringer's HERNEXEOS® approved in China as first oral tar…
8 months ago
financialpost.com
1:06
New FDA Approval | Hernexeos (zongertinib) for HER2-Mutated No…
162 views2 months ago
YouTubeGO2 for Lung Cancer
See more videos
Static thumbnail place holder